ORBIMED ADVISORS LLC 13D and 13G filings for Applied Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 6:30 pm Sale |
2023-12-31 | 13G | Applied Therapeutics, Inc. APLT |
ORBIMED ADVISORS LLC | 0 0.000% |
-7,300,921 (Position Closed) |
Filing |
| 2023-02-14 4:07 pm Purchase |
2022-12-31 | 13G | Applied Therapeutics, Inc. APLT |
ORBIMED ADVISORS LLC | 7,300,921 9.990% |
5,200,240 (+247.55%) |
Filing |
| 2022-02-11 4:14 pm Purchase |
2021-12-31 | 13G | Applied Therapeutics, Inc. APLT |
ORBIMED ADVISORS LLC | 2,100,681 8.000% |
433,856 (+26.03%) |
Filing |
| 2021-02-12 4:41 pm Purchase |
2020-12-31 | 13G | Applied Therapeutics, Inc. APLT |
ORBIMED ADVISORS LLC | 1,666,825 7.410% |
817,571 (+96.27%) |
Filing |